about
Association of maternal serum concentrations of 2,2', 4,4'5,5'-hexachlorobiphenyl (CB-153) and 1,1-dichloro-2,2-bis (p-chlorophenyl)-ethylene (p,p'-DDE) levels with birth weight, gestational age and preterm births in Inuit and European populationsSocioeconomic inequalities in mortality from conditions amenable to medical interventions: do they reflect inequalities in access or quality of health care?Seasonal variation of overall and cardiovascular mortality: a study in 19 countries from different geographic locations.Impact of PCB and p,p'-DDE contaminants on human sperm Y:X chromosome ratio: studies in three European populations and the Inuit population in Greenland.Socioeconomic differences in the use of ill-defined causes of death in 16 European countriesHazard quotient profiles used as a risk assessment tool for PFOS and PFOA serum levels in three distinctive European populations.Is the fact of parenting couples cohabitation affecting the serum levels of persistent organohalogen pollutants?The contribution of educational inequalities to lifespan variation.Associations between DSM-IV mental disorders and subsequent onset of arthritis.Long-term mortality after stroke is higher than after myocardial infarction.Association between mental disorders and subsequent adult onset asthma.Associations between DSM-IV mental disorders and subsequent heart disease onset: beyond depressionAssociations between mental disorders and subsequent onset of hypertension.The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative.Cross-sectional Comparison of the Epidemiology of DSM-5 Generalized Anxiety Disorder Across the Globe.The turn of the gradient? Educational differences in breast cancer mortality in 18 European populations during the 2000s.Assessing the potential impact of increased participation in higher education on mortality: evidence from 21 European populations.Gender-specific mortality associated with alcohol consumption in Poland in transition.Short-term effects of nitrogen dioxide on mortality: an analysis within the APHEA project.Contribution of smoking to socioeconomic inequalities in mortality: a study of 14 European countries, 1990-2004.Health outcomes and economic consequences of using angiotensin-converting enzyme inhibitors in comparison with angiotensin receptor blockers in the treatment of arterial hypertension in the contemporary Polish setting.Trends In Inequalities In Mortality Amenable To Health Care In 17 European Countries.Prevalence of psychiatric morbidity in Polish population - national health interview survey.Prevalence of insomnia in Poland - results of the National Health Interview Survey.Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey.[A new version of cardiovascular risk assessment system and risk charts calibrated for Polish population].Educational inequalities in cancer mortality differ greatly between countries around the Baltic Sea.["Epidemiology of mental disorders and access to mental health care. EZOP - Poland" - research methodology].Perinatal mortality in Matlab, Bangladesh: a community-based study.Educational inequalities in mortality in four Eastern European countries: divergence in trends during the post-communist transition from 1990 to 2000.Prevalence and control of cardiovascular risk factors in Poland. Assumptions and objectives of the NATPOL 2011 Survey.More variation in lifespan in lower educated groups: evidence from 10 European countries.Towards estimating the burden of disease attributable to second-hand smoke exposure in Polish children.Socioeconomic inequalities in homicide mortality: a population-based comparative study of 12 European countries.Variations in the relation between education and cause-specific mortality in 19 European populations: a test of the "fundamental causes" theory of social inequalities in health.Characteristics of sleep disturbances in Poland - results of the National Health Interview Survey.Cerebrovascular diseases in Poland-inconsistent seasonal patterns of hospitalisation and mortality.Incidence, treatment, in-hospital mortality and one-year outcomes of acute myocardial infarction in Poland in 2009-2012--nationwide AMI-PL database.Different convergence parameters applied to the S-PLUS GAM function.Acute Ischemic Stroke Hospital Admissions, Treatment, and Outcomes in Poland in 2009-2013.
P50
Q34149335-CCB7CA17-2B75-4EDD-858A-32C7DB0D018BQ34266394-5793125D-9F5B-4286-880E-3DA7890CB7E2Q34566238-F13050A9-E3F5-46D7-88AB-89F791DD2BAEQ34603142-86F75720-B8AB-4EBE-9C45-168092FFB26AQ34996088-39B6D952-5243-4B99-A472-66E83AB4E673Q35469973-7227D3C3-C278-4279-8209-7089DD770403Q35594023-90BA1CD8-C75F-483A-9F59-E2532F1F4A08Q35822424-07BE299F-689F-4BCD-BEE4-F7D7E58369FEQ36945875-A4E14391-AC60-4550-B93E-AE6605EFB9A5Q36990124-05E8ADCE-C3DB-40F0-9479-E1E962B36C58Q37431465-0577DFF3-065E-487C-807C-D21A94A91941Q37455383-8B389FD3-7D12-4040-8C8B-FC0BE08EB426Q37718053-1761DF31-B471-4FE7-969B-AAC92BBB3AE0Q38653144-C7451F09-CBFB-44A0-B178-4F3197A7E28EQ38905913-76297B1C-BC83-445E-BBA2-40EF162914EFQ38924493-195E9CA1-46B2-423E-9B98-7DCBC2666AF4Q39153522-37B4DA23-A6D7-4D3C-8717-BD359C85C85FQ39740006-E6F0D6AC-AA6C-4769-A89F-CF01DEBAA3F4Q39748817-EF6611EA-6727-477B-BB48-1FA0D36F3835Q39815898-987A62B2-16B5-47E9-A9A3-134F9F4C44F6Q39823209-1F76CF9E-4E30-444A-A09F-DA72F2F16F72Q40171849-57552472-2E40-4488-A748-A25DC1F650CDQ40360121-54D4F279-E6BC-459A-8C0D-704616B7633EQ40360139-BFF040F0-23FA-4B81-80B7-F272C5F19A86Q40838547-B70044C2-DE43-4427-992F-26192983B448Q41161581-9928FFF9-1F5A-4512-9B88-A96114A1996FQ43878402-14A81127-40F4-47AC-BC89-343D6A78A572Q44043717-E2EBD17C-A76D-4944-AE8A-9AAF39E0BE03Q44522890-A7E09598-E6E4-4296-B98D-3858A3C2D63FQ44885003-53F215D9-DFB6-47C9-8155-15565D94C2E1Q44967292-920CB322-7B72-4B0E-B2A9-03AADBE802A3Q46058632-DBAD6643-D7CF-4476-8B88-49604710FDA7Q46317606-0BFF383D-1A99-4F71-B2D3-CA4C3D6B5849Q47345494-4C71F860-E25E-4155-80C7-56690BBA40E2Q47633016-ADAAFB23-2A4A-43D0-87F5-C94BEE1F555DQ48591677-19A5D233-06E0-44BD-954F-27DA0B254051Q50094156-C188B28A-D049-4AB3-B404-87F7A3B6EB70Q51037555-A5E3540E-BBAB-4DAE-9F01-28ADE37C0762Q52945284-98720B26-E50D-4AE3-921F-826407DD8F6FQ55118210-E776BB90-3E04-486E-8DD4-D426EB8CE2C7
P50
description
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Bogdan Wojtyniak
@ast
Bogdan Wojtyniak
@en
Bogdan Wojtyniak
@es
Bogdan Wojtyniak
@nl
type
label
Bogdan Wojtyniak
@ast
Bogdan Wojtyniak
@en
Bogdan Wojtyniak
@es
Bogdan Wojtyniak
@nl
prefLabel
Bogdan Wojtyniak
@ast
Bogdan Wojtyniak
@en
Bogdan Wojtyniak
@es
Bogdan Wojtyniak
@nl
P214
P244
P106
P1153
7006364280
P21
P214
P244
no96030376
P31
P496
0000-0002-2135-8226
P735
P7859
lccn-no96030376